Investors in Health

SCE Freiraum Ventures is a venture capital investor focused on early-stage startups. They back teams and accompany them throughout their journey. SCE Freiraum Ventures are experts in education and acceleration of early-stage teams. Their home is the Strascheg Center for Entrepreneurship (SCE), the Entrepreneurship Center of the Munich University of Applied Sciences.

They invest in companies that are run by people they value both personally and professionally, whose drive they share, and whose plans convince them. They don't want to limit themselves to a specific topic—they just want to understand it. They want to think along and question things. They aim to communicate as partners on an equal footing, celebrating successes together and facing defeats together.

Starthub-ventures focuses on Pre-Seed investments. They assist not only with Pre-Seed capital for their portfolio companies but also have a vast network that extends particularly across international logistics. Starthub-ventures supports the heroes of tomorrow, who are on their way from Zero to Hero.

LSI is a pre-seed and seed stage venture capital in Poland. We invest in early-stage start ups in life science domain. LSI is a Venture Capital Fund focused on polish life science startups in pre-seed and seed stages. We currently have 11 start-ups in our portfolio. We have startups in the field of medtech, digital health, biotech, environment protection.

MD Start is an incubator and fund dedicated to medical technologies. MD Start is a fund, a team of entrepreneurs and an incubator combined, aimed at transforming innovative ideas into medical realities. Our mission is to incubate medical device innovations to the point where proof-of-principle in patients is demonstrated, allowing for interest from traditional investors and our continued funding.

Venture Fund and Accelerator. NEXT MONDAY backs the world of founders in German, Dutch, and English-speaking countries, igniting their B2B innovations into business success. B2B ain't no walk in the park. Spinning wheels cost the most in terms of losing time to market, and a vital network is your passport to serve it. We've been there, done that, and we know the rollercoaster of challenges and opportunities like the back of our hands.

At SHS Capital, they are committed to building European healthcare champions by helping to accelerate their portfolio companies' growth. They achieve this by adhering to high ethical and sustainable standards. If you are looking for the right partner to bring your healthcare company to the next level.

NHS Innovation Accelerator accelerates adoption and spread of high impact innovations across the NHS for patient and population benefit. The NHS Innovation Accelerator (NIA) is an NHS England Initiative delivered in partnership with the country’s 15 Health Innovation Networks (HINs) and the Accelerated Access Collaborative. Hosted by UCLPartners, it supports delivery of the Five Year Forward View by accelerating uptake of high impact innovations for patient, population and NHS staff benefit, and providing real time practical insights on spread to inform national strategy.

NLC is the European healthtech venture builder, bringing science-based healthtech inventions to life. NLC Health Ventures - is dedicated to advancing health, making it accessible for everyone. By using entrepreneurship at scale, our unique NLC approach allows us to find inventions, and create and support ventures that have the potential to reach the patient. Led by winning teams, together with a dedicated network and driven by data and learnings.

PVP is a private venture capital firm based in Berlin, investing in early-stage healthcare companies across Europe with a focus on medical device, digital health, and platform technology companies. Peppermint VenturePartners was established in 2008 by Ingeborg Neumann, Dr. Joachim Rautter and Dr. Klaus Stöckemann.

Nucleus Capital is a Climate Deep-Tech VC that invests in early-stage ventures focusing on programmable biology, food technology, and green industrials. They partner with purpose-driven entrepreneurs to address systemic challenges to planetary health, providing funding and sector-specific expertise. Their investments range from €150k to €1 million, targeting startups in Europe and the US.

Apollo Health Ventures is a transatlantic early-stage venture capital firm focused on investing in transformative healthcare companies targeting age-related diseases and aging itself. They leverage a combination of traditional funding and venture building to create value in Europe and the US, partnering with scientific experts and top institutions. Their approach aims to enable breakthroughs in biotechnology to enhance healthy lifespans and reduce healthcare costs.